title: Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival.
authors.forename: Evelien A N
authors.initials: EA
authors.lastname: Oostdijk
authors.forename: Anne Marie G A
authors.initials: AM
authors.lastname: de Smet
authors.forename: Marc J M
authors.initials: MJ
authors.lastname: Bonten
mesh_terms: D061605:Administration, Intravenous; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002439:Cefotaxime / Q000008:administration & dosage; D016000:Cluster Analysis; D003091:Colistin / Q000008:administration & dosage; D003422:Critical Care / Q000379:methods*; D003428:Cross Infection / Q000401:mortality* / Q000517:prevention & control*; D018592:Cross-Over Studies; D003666:Decontamination / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D041981:Gastrointestinal Tract / Q000187:drug effects / Q000382:microbiology*; D017052:Hospital Mortality; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data; D007441:Intubation, Gastrointestinal; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D016017:Odds Ratio; D009960:Oropharynx / Q000187:drug effects / Q000382:microbiology*; D011322:Primary Prevention / Q000379:methods; D016019:Survival Analysis; D014031:Tobramycin / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000666:Amphotericin B; D002439:Cefotaxime; D014031:Tobramycin; D003091:Colistin